Home ›
Trademark Categories ›
Pharmaceuticals ›
2009 ›
SW ›
SWINFLUNOV
Trademark search for:
SWINFLUNOV
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2009-05-04 — Application filed
2009-05-07 — Application filed
2009-05-07 — Application filed
2009-05-08 — Notice of design search code mailed
2009-07-24 — Final disposition recorded
2009-07-24 — Assigned to examiner
2009-07-27 — Final disposition recorded
2009-09-16 — Approved for pub - principal register
2009-09-28 — Assigned to lie
2009-09-28 — Law office publication review completed
2009-10-14 — Notice of publication
2009-11-03 — Published for opposition
2010-01-26 — Noa mailed - sou required from applicant
2010-07-01 — Sou teas extension received
2010-07-01 — Sou extension 1 filed
2010-07-01 — Sou extension 1 granted
2010-07-03 — Notice of approval of extension request mailed
2011-01-24 — Sou teas extension received
2011-01-24 — Sou extension 2 filed
2011-02-12 — Case assigned to intent to use paralegal
2011-02-12 — Sou extension 2 granted
2011-02-15 — Notice of approval of extension request mailed
2011-06-16 — Teas petition to amend basis received
2011-06-20 — Assigned to petition staff
2011-06-22 — 44(e) petition - granted
2011-06-22 — Attorney review/decision on amendment required
2011-06-23 — Attorney review completed
2011-06-23 — Notice of allowance cancelled
2011-07-06 — Notice of publication
2011-07-26 — Published for opposition
2011-10-11 — Registered-principal register
2017-01-31 — Correspondence received in law office
2017-04-05 — Review of correspondence complete - address updated
2018-05-18 — Cancelled sec. 8 (6-yr)
2018-05-18 — Final status recorded
Owner Information
Novartis AG
Novartis AG
Novartis AG
Correspondent
NANCY SABARRA FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
